Josephine Feliciano Selected Research

Josephine Feliciano Research Topics

16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 05/2013
16	Neoplasms (Cancer) 02/2024 - 01/2013
5	Lung Neoplasms (Lung Cancer) 11/2023 - 01/2019
2	Melanoma (Melanoma, Malignant) 01/2023 - 01/2019
2	Chronic Obstructive Pulmonary Disease (COPD) 07/2017 - 09/2014
1	Mesothelioma 01/2023
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023
1	Neoplasm Metastasis (Metastasis) 12/2021
1	Pneumonia (Pneumonitis) 01/2021
1	COVID-19 01/2020
1	Chronic Disease (Chronic Diseases) 01/2020
1	Recurrent respiratory papillomatosis 01/2019
1	Residual Neoplasm 01/2019
1	Death (Near-Death Experience) 01/2019
1	Sialadenitis 01/2019
1	Sjogren's Syndrome (Sjogren Syndrome) 01/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Pathologic Complete Response 01/2018
1	Hemorrhage 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Leukemia 01/2017
1	Anemia 01/2017
1	Neutropenia 01/2017
1	Fatigue 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Thromboembolism 01/2017
1	Mucositis 01/2017
1	Exanthema (Rash) 01/2017
1	Disease Progression 01/2015
1	Carcinogenesis 09/2014
1	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2011

7	Immune Checkpoint InhibitorsIBA 12/2023 - 09/2017
5	Biomarkers (Surrogate Marker)IBA 11/2023 - 09/2014
3	NivolumabIBA 01/2021 - 09/2017
3	PlatinumIBA 01/2017 - 01/2015
2	Tyrosine Kinase InhibitorsIBA 02/2024 - 12/2021
2	pembrolizumabIBA 01/2019 - 09/2017
2	LigandsIBA 01/2019 - 09/2017
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2016 - 11/2016
2	Cisplatin (Platino)FDA LinkGeneric 11/2016 - 11/2016
1	Anaplastic Lymphoma KinaseIBA 02/2024
1	osimertinibIBA 12/2021
1	ErbB Receptors (EGF Receptor)IBA 12/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	SteroidsIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Infliximab (Remicade)FDA Link 01/2021
1	3-chloro-2,5,6-trimethylbenzoateIBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	Therapeutic UsesIBA 01/2019
1	avelumabIBA 01/2019
1	Circulating Tumor DNAIBA 01/2019
1	IpilimumabIBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2017
1	atezolizumabIBA 09/2017
1	AntibodiesIBA 09/2017
1	Sunitinib (Sutent)FDA Link 01/2017
1	Bevacizumab (Avastin)FDA Link 01/2017
1	Dinoprostone (PGE2)FDA Link 01/2015
1	Pemetrexed (MTA)FDA Link 01/2015
1	apricoxibIBA 01/2015
1	Docetaxel (Taxotere)FDA Link 01/2015
1	EnzymesIBA 09/2014
1	ProgranulinsIBA 09/2014

13	Therapeutics 02/2024 - 05/2013
7	Immunotherapy 11/2023 - 09/2017
5	Drug Therapy (Chemotherapy) 01/2020 - 05/2013
3	Neoadjuvant Therapy 01/2021 - 07/2017
1	Palliative Care (Palliative Therapy) 01/2019
1	Combination Drug Therapy (Combination Chemotherapy) 01/2017
1	Radiotherapy 01/2013
1	Hematopoietic Stem Cell Transplantation 09/2011
1	Liver Transplantation 09/2011